New York Oncology Hematology, PC

Summary

New York Oncology Hematology, PC is a medical facility located in Albany, New York. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Prostate Cancer, Non-Small Cell Lung Cancer and other specialties. New York Oncology Hematology, PC is involved with conducting 185 clinical trials across 169 conditions. There are 5 research doctors associated with this hospital, such as Karen Tedesco, Mihir Raval, MD, Rahul Ravilla, MD, and Lawrence E. Garbo, MD.

Top PIs

Clinical Trials running at New York Oncology Hematology, PC

Lung Cancer

Cancer

Follicular Lymphoma

Colorectal Cancer

Ovarian Cancer

Non-Hodgkin's Lymphoma

Melanoma

Non-Small Cell Lung Cancer

Breast Cancer

Diffuse Large B-Cell Lymphoma

MK-1084 + Pembrolizumab

for Lung Cancer

Researchers want to learn if the study medicines MK-1084 and subcutaneous (SC) pembrolizumab can be used to treat non-small cell lung cancer (NSCLC) when given together. MK-1084 is a targeted therapy for the KRAS G12C mutation. The goal of this study is to learn if people who receive MK-1084 with SC pembrolizumab live longer without the cancer growing or spreading than in people who receive SC pembrolizumab with chemotherapy.

Recruiting

2 awards

Phase 3

1 criteria

Tarlatamab

for Small Cell Lung Cancer

The primary objective of this study is to describe the antitumor activity of tarlatamab in participants with small cell lung cancer (SCLC).

Recruiting

1 award

Phase 2

4 criteria

V940 + Pembrolizumab

for Lung Cancer

This trial is testing a new treatment combination of V940 and pembrolizumab in patients who have had surgery to remove Stage II, IIIA, or IIIB non-small cell lung cancer. The goal is to see if this new combination can help prevent the cancer from coming back. V940 and pembrolizumab work together to help the immune system find and destroy any leftover cancer cells.

Recruiting

1 award

Phase 3

7 criteria